Taiwan-based Medigen Vaccine Biologics Corp. said Thursday that all 1,030 participants in its Phase 3 clinical trial in Paraguay have received their first vaccine shot of either the Medigen or AstraZeneca COVID-19 vaccines.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
AI boom lifts Taiwan's manufacturing PMI to expansion in October
11/03/2025 10:02 PM - Society
3 Vietnamese convicted for fraud in Changhua County
11/03/2025 09:31 PM - Society
Train service in Chiayi County resumes after fatal track accident
11/03/2025 07:54 PM - Business
Starlux to start Miyako Islands flights from Taichung, Taoyuan in Feb.
11/03/2025 07:39 PM - Politics
Taiwan's APEC 'visibility' has improved: APEC envoy
11/03/2025 07:31 PM